Terms: = Head and neck cancer AND ARID1A, BAF250, 8289, ENSG00000117713, SMARCF1, C1orf4, BM029, B120, RP1-50O24_1, P270, BAF250a AND Treatment
37930 results:
1. Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma.
Lv H; Zhang F; Huang C; Xu S; Li J; Sun B; Gai C; Liu Z; Wang M; Li Z; Tian Z
J Cancer Res Clin Oncol; 2024 May; 150(5):260. PubMed ID: 38760614
[TBL] [Abstract] [Full Text] [Related]
2. Robotic and endoscopic trans-oral total laryngectomy, a systematic review and meta-analysis.
Tumlin P; Dugan B; Hassid S; Lawson G; Turner M
J Robot Surg; 2024 May; 18(1):214. PubMed ID: 38758418
[TBL] [Abstract] [Full Text] [Related]
3. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
[TBL] [Abstract] [Full Text] [Related]
4. Toripalimab plus chemotherapy in American patients with recurrent or metastatic nasopharyngeal carcinoma: A cost-effectiveness analysis.
Lian D; Gan Y; Xiao D; Xuan D; Chen Y; Yang Y
Cancer Med; 2024 May; 13(10):e7243. PubMed ID: 38752448
[TBL] [Abstract] [Full Text] [Related]
5. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract] [Full Text] [Related]
6. Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.
He C; Mi X; Xu G; Xu X; Xin W; Zhong L; Zhu J; Shu Q; Fang L; Ding H
PLoS One; 2024; 19(5):e0302961. PubMed ID: 38748691
[TBL] [Abstract] [Full Text] [Related]
7. Interventional radiotherapy (brachytherapy) for re-irradiation of recurrent head and neck malignancies: oncologic outcomes and morbidity.
Bussu F; Fionda B; Rigante M; Rizzo D; Loperfido A; Gallus R; De Luca LM; Corbisiero MF; Lancellotta V; Tondo A; D'Aviero A; Mattiucci GC; Kovacs G; Galli J; Tagliaferri L
Acta Otorhinolaryngol Ital; 2024 May; 44(Suppl. 1):S28-S36. PubMed ID: 38745514
[TBL] [Abstract] [Full Text] [Related]
8. Long-term prognosis after endoscopic submucosal dissection for esophageal cancer in older adult patients.
Konishi H; Urabe Y; Nakamura T; Ishibashi K; Mizuno J; Fukuhara M; Takasago T; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Ishikawa A; Oka S
BMC Gastroenterol; 2024 May; 24(1):164. PubMed ID: 38745162
[TBL] [Abstract] [Full Text] [Related]
9. [treatment strategy for low-risk papillary thyroid carcinoma with diameter smaller than 1 cm: immediate surgery vs active surveillance].
Sun W; Liu Q; Zhang H
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1572-1577. PubMed ID: 38742343
[TBL] [Abstract] [Full Text] [Related]
10. Acute Airway Obstruction: An Unusual Presentation of Posttransplant Lymphoproliferative Disorder in a Renal Transplant Recipient.
Aggarwal J; Kumar DJ; Rathore V; Mehta R; Kumar A; Ravina M
Exp Clin Transplant; 2024 Apr; 22(4):307-310. PubMed ID: 38742322
[TBL] [Abstract] [Full Text] [Related]
11. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis.
Ranjitham PS; Kuzhali S; Sumathy MP; Gnandeepam S
Indian J Dent Res; 2023 Oct; 34(4):417-421. PubMed ID: 38739824
[TBL] [Abstract] [Full Text] [Related]
13. Acupuncture for Chronic Radiation-Induced Xerostomia in head and neck cancer: A Multicenter Randomized Clinical Trial.
Cohen L; Danhauer SC; Garcia MK; Dressler EV; Rosenthal DI; Chambers MS; Cusimano A; Brown WM; Ochoa JM; Yang P; Chiang JS; Gordon O; Crutcher R; Kim JK; Russin MP; Lukenbill J; Porosnicu M; Yost KJ; Weaver KE; Lesser GJ
JAMA Netw Open; 2024 May; 7(5):e2410421. PubMed ID: 38739392
[TBL] [Abstract] [Full Text] [Related]
14. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
[TBL] [Abstract] [Full Text] [Related]
15. Adenoid Cystic Carcinoma Mimicking Bronchial Asthma.
Garg K; Binji SK
J Assoc Physicians India; 2023 Dec; 71(12):89-90. PubMed ID: 38736058
[TBL] [Abstract] [Full Text] [Related]
16. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
[TBL] [Abstract] [Full Text] [Related]
17. Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Ikoma T; Matsumoto T; Boku S; Motoki Y; Kinoshita H; Kosaka H; Kaibori M; Inoue K; Sekimoto M; Fujisawa T; Iwai H; Naganuma M; Tanizaki H; Hisamatsu Y; Okada H; Kurata T
Cancer Immunol Immunother; 2024 May; 73(7):126. PubMed ID: 38733406
[TBL] [Abstract] [Full Text] [Related]
18. The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.
Jin YN; Qiang MY; Wang Y; Lin YJ; Jiang RW; Cao WW; Zhang WJ; Wang SY; Zhang HY; Yao JJ
Cancer Immunol Immunother; 2024 May; 73(7):125. PubMed ID: 38733402
[TBL] [Abstract] [Full Text] [Related]
19. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract] [Full Text] [Related]
20. Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma.
Yue P; Bie F; Zhu J; Gao LR; Zhou Z; Bai G; Wang X; Zhao Z; Xiao ZF; Li Y; Zhou A; Liu WY; Jiao Y; Gao S
Mol Cancer; 2024 May; 23(1):96. PubMed ID: 38730415
[TBL] [Abstract] [Full Text] [Related]
[Next]
